CRIS

NASD Curis, Inc.
Nov 18, 2026 · 4:11 PM ET LAST TRADE Market Closed

$0.6058 ↑ +0.0640 (+11.81%) Trading Up from the previous close of $0.5418, $0.0071 below the day’s high of $0.6129

YTD change
-96.93%
vs 20-day SMA
+3.17%
vs 200-day SMA
-92.40%

Price ranges

Previous day
$0.4489 $0.5500
open $0.4708 close $0.5418
+$0.0710 (+15.08%)
Today
$0.4830 $0.6129
open $0.5230 now $0.6058
+$0.0828 (+15.83%)
Past week
$0.4162 $0.6609
from $0.6530 now $0.6058
-$0.0472 (-7.23%)
Past month
$0.3625 $1.6000
from $0.3996 now $0.6058
+$0.2062 (+51.60%)
This year
$0.1806 $19.7420
from $19.7420 now $0.6058
-$19.1362 (-96.93%)

Price & Performance

+0.06 (+12.87%) / 6M

$-0.2529$1.96$4.18$6.40May 18Aug 18Nov 17

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 100.0% away from all-time highs of $7,440.0000
  • CRIS is down 97% since the beginning of the year
  • CRIS is down 98% over the past 12 months
  • CRIS is up 52% over the past 1 month
  • 8% of all CRIS investors are betting against CRIS

CRIS reads not so good: price sits above one of the two key moving averages, the 12-month move is -56.0%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-1.94
Earnings momentum -115.6% Quarterly EPS growth
Quarterly change -115.6%

Valuation

P/E ratio 0.35
Enterprise value $-2554010.0
Beta 5.04

Balance sheet & scale

IncomeN/A
Revenue$1.1M
Cash$5.6M
Debt$740.0
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $13.6M

Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170 and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. The CA-170 pipeline is an also an orally-available small molecule antagonist of PD-L1 and VISTA immune checkpoints. The company was founded on February 14, 2000 and is headquartered in Lexington, MA.

Competitor comparison

TickerCompany PriceChange
CMXHF CSL Limited $136.78 -1.71%
ARGX argenx SE Sponsored ADR $947.52 -0.36%
ONC BeOne Medicines Ltd. Sponsored ADR $413.26 +0.48%
WXIBF Wuxi Biologics (Cayman) Inc. $5.97 +0.51%
INCY Incyte Corporation $119.09 -0.98%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.